Rheos Capital Works’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-57,666
Closed -$3.04M 101
2023
Q3
$3.04M Hold
57,666
0.18% 112
2023
Q2
$3.7M Hold
57,666
0.2% 88
2023
Q1
$3.08M Hold
57,666
0.17% 94
2022
Q4
$3.09M Buy
57,666
+11,000
+24% +$568K 0.19% 117
2022
Q3
$2.15M Hold
46,666
0.14% 134
2022
Q2
$2.57M Sell
46,666
-34,674
-43% -$2.24M 0.19% 122
2022
Q1
$5.57M Hold
81,340
0.27% 107
2021
Q4
$6.44M Buy
81,340
+23,240
+40% +$1.94M 0.28% 103
2021
Q3
$4.59M Buy
+58,100
New +$4.67M 0.24% 103

Other funds holding ENOV

Rheos Capital Works's ENOV Position: Q4 2023 in Review

Rheos Capital Works sold out of Enovis (ENOV) in Q4 2023, closing a stake of 57,666 shares — an estimated $3.04M sold.

Rheos Capital Works first reported a position in ENOV in Q3 2021 and held it in 9 quarters. The position peaked at $6.44M in Q4 2021. 290 funds tracked by Wall St. Rank hold ENOV as of Q4 2023.

  • Rheos Capital Works reported no remaining Enovis position as of Q4 2023 after selling out during the quarter.
  • Rheos Capital Works sold 57,666 Enovis shares in Q4 2023, an estimated $3.04M.
  • Rheos Capital Works first reported a position in Enovis in Q3 2021 and held it in 9 quarters.
  • Rheos Capital Works's Enovis position peaked at $6.44M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held Enovis as of Q4 2023.

Based on Rheos Capital Works's 13F filing for Q4 2023, filed 16 Jan 2024.